1. FDA approves new oral drug to treat multiple sclerosis [Internet]. U.S. Food & Drug Administration. 2019. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-oral-drug-treat-multiple-sclerosis. [Last cited on 2019 Mar 26].
2. Fingolimod for multiple sclerosis and emerging indications: Appropriate patient selection, safety precautions, and special considerations;Ayzenberg;Ther Clin Risk Manag,2016
3. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): A double-blind, randomised, placebo-controlled, phase 3 trial;Calabresi;Lancet Neurol,2014
4. Melanoma occurring during treatment with fingolimod for multiple sclerosis: A case report;Conzett;Arch Dermatol,2011
5. Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis;Haebich;Clin Exp Dermatol,2016